Rel. Chemotex (RELCHEMQ)
Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹118.99 |
| Market Cap | ₹89.76 Cr |
| P/E Ratio | 17.07 |
| ROCE | 6.81% |
| ROE | 3.97% |
| Dividend Yield | 0.42% |
| Profit Growth | 28.84% |
| Debt/Equity | 1.87 |
| Sales Growth | 6.54% |
| Promoter Holding | 67.68% |
| 52-Week Range | ₹104.1 — ₹163 |
| Sector | Textiles & Apparels |
| Book Value | ₹188.87 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹123, with book value of ₹184.83, the market is pricing this textile business at a 33% discount to net assets. That catches my attention, but as Graham warned, a low price-to-book can be a trap when debt is high and earnings are weak. Debt-to-equity of 1.80 bothers me; this is not a fortress balance sheet. ROE is only 3.97% and ROCE is 6.81%, so the underlying business generates returns well below what a shareholder should demand. Sales fell 11.16%, which is not the kind of momentum I like. Yes, profit growth of 321.05% looks exciting, but that is from a small base; the latest quarter earned just ₹1 crore on ₹82 crore of sales—a margin of about 1.2%. One good quarter does not make a great investment. The Piotroski score of 6/9 is a hopeful sign, and promoter holding of 67.68% means owners are aligned with us. But with a P/E of 17.25 and a dividend yield of only 0.41%, I am not being paid to wait. What would make me interested? A clear reduction in debt, consistent sales recovery, and margins that stay above the cost of capital. Until then, this is a possible turnaround and asset story, not a business I would bet heavily on. The margin of safety from book value is real only if that book value is sound and earning power is returning. I need more evidence.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer